Mike Mensinger serves as Executive at Beta Bionics, Inc., where they oversee executive responsibilities. Since joining the company, Mike Mensinger has executed 2 insider transactions totaling $51.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 2, 2025 involved selling 1,063 shares valued at $31.2K.
Mike Mensinger currently holds 90,752 shares of Beta Bionics, Inc. (BBNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mike Mensinger has been a net seller of BBNX stock. They have purchased $0 and sold $51.7K worth of shares.
Mike Mensinger's most recent insider trade was on Dec 2, 2025, when they sold 1,063 shares at $29.34 per share.
Get notified when new Form 4 filings are submitted
| $18.86 |
| Discretionary |